CenterGene
CenterGene was established in July 2014. It possesses comprehensive R&D capabilities in early screening of macromolecular drugs, cell line construction, small-scale research, pilot-scale amplification, quality research, and non-clinical and clinical drug research. Shengji Pharmaceutical focuses on the R&D and industrialization of highly technical recombinant glycoprotein drugs, possessing core technological barriers and a large number of core intellectual property rights, including authorized patents and trade secrets. It is a leading enterprise in the R&D and industrialization of recombinant glycoprotein hormone drugs in China.[centergene.com]
-
About Follitropin alfa Follitropin alfa is a fertility medication containing recombinant human Follicle-Stimulating Hormone (FSH) used to stimulate egg development in […]
